Yatırımcı.AI

TRILC vs YBTAS Comparison

Price, market cap, valuation, profitability and leverage metrics of TRILC and YBTAS side by side.

TRILCYBTAS
StockFund

If you had invested TRY 10,000

Metric comparison

TRILC vs YBTAS Comparison
MetricTRILCYBTASSector median
Last price (TL)0.9110.8018.72
Daily change1.11%0.19%−4.63%
Market capTRY 943.7MTRY 3.2BTRY 4.4B
P/E—45.1718.20
P/B0.471.591.14
Return on equity−4.59%3.52%1.78%
Free float73.16%9.82%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the TRILC vs YBTAS comparison

Price, market cap, valuation multiples, profitability and leverage of TRILC (Türk İlaç Serum) and YBTAS (Yibitas İnşaat Malzeme) side by side as of Sep 28, 2026, 10:00. Of the 15 metrics compared, TRILC leads in 5 and YBTAS leads in 10.

Highlights: Daily change: TRILC leads (1.11% vs 0.19%). Market cap: YBTAS leads (TRY 3.2B vs TRY 943.7M). P/B: TRILC leads (0.47 vs 1.59). EV/EBITDA: TRILC leads (3.67 vs 8.49). EV/Sales: YBTAS leads (3.12 vs 3.61). Gross margin: YBTAS leads (25.89% vs 25.29%). EBITDA margin (annual): TRILC leads (27.80% vs 24.32%). Net margin (annual): YBTAS leads (3.84% vs −1.65%).

Frequently asked questions

By P/E, Tie is cheaper (— vs 45.17); by P/B, TRILC trades at the lower multiple (0.47 vs 1.59).

Annual net margin is −1.65% for TRILC and 3.84% for YBTAS; return on equity is −4.59% for TRILC and 3.52% for YBTAS.

The leverage ratio is 76.53 for TRILC and 25.95 for YBTAS; net debt/EBITDA is 2.88 for TRILC and −0.02 for YBTAS. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.